Establishment and characterization of a novel human endometrial mesenchymal stem cell line from a patient with adenomyosis

In: Cell and Tissue Biology · 2016 · vol. 10(1) , pp. 10–17 · doi:10.1134/s1990519x16010107 · W2299995930
article OA: closed CC0 ⤵ 3 in-corpus citations
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-12

This study established and characterized a human endometrial mesenchymal stem cell line from an adenomyosis patient, finding it shares surface marker expression and adipogenic potential with healthy donor cells but exhibits chromosomal abnormalities before entering senescence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

The study established a novel human endometrial mesenchymal stem cell (eMSC) line from a patient with adenomyosis and compared its properties with eMSCs derived from a healthy donor. The patient- and donor-derived cells both showed fibroblast-like morphology, had similar expression of surface markers, and did not differ in adipogenic potential, while karyotype analysis at passages 6–7 found that the healthy donor cells were mostly normal but the adenomyosis-derived cells commonly had chromosomal abnormalities, particularly aneuploidy and more frequent nonrandom breaks involving chromosomes 7 and 11. The authors report that despite karyotypic instability, the adenomyosis-derived eMSCs stopped cycling after about 26 passages and entered replicative senescence, indicating the observed abnormalities were not associated with transformation/immortalization in vitro. This paper is centrally about adenomyosis — it establishes and characterizes an eMSC line specifically from an adenomyosis patient.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis, previously termed “endometriosis interna,” is a widespread disease affecting the female reproductive system and frequently resulting in infertility in women. The aim of this work was to examine the properties of endometrial mesenchymal stem cells (eMSCs) from a patient with adenomyosis. We established the cell line from a patient with adenomyosis and compared the properties of these cells with cells derived from a healthy donor. It was found that patient-derived eMSCs and eMSCs from healthy donors had a fibroblast-like morphology and did not differ in expression of surface markers and adipogenic potential. Karyotype analysis of G-banded metaphase chromosomes was performed in cells of both lines at the six or seventh passages. Cells from the healthy donor mostly had normal karyotype. Karyotype of eMSCs from the patient with adenomyosis usually had chromosomal abnormalities. The abnormalities concerned aneuploidy and nonrandom chromosomes breaks more often involving chromosomes 7 and 11. Although karyotype instability may be a sign of cell transformation, the patient-derived eMSCs stopped cycling after about 26 passages and entered into replicative senescence. This shows that the karyotypic abnormalities that we observed in adenomyosis-derived eMSCs are not relevant to the cell transformation and immortalization in vitro.
Full text 10,280 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Adenomyosis, previously termed “endometriosis interna,” is a widespread disease affecting the female reproductive system and frequently resulting in infertility in women. The aim of this work was to examine the properties of endometrial mesenchymal stem cells (eMSCs) from a patient with adenomyosis. We established the cell line from a patient with adenomyosis and compared the properties of these cells with cells derived from a healthy donor. It was found that patient-derived eMSCs and eMSCs from healthy donors had a fibroblast-like morphology and did not differ in expression of surface markers and adipogenic potential. Karyotype analysis of G-banded metaphase chromosomes was performed in cells of both lines at the six or seventh passages. Cells from the healthy donor mostly had normal karyotype. Karyotype of eMSCs from the patient with adenomyosis usually had chromosomal abnormalities. The abnormalities concerned aneuploidy and nonrandom chromosomes breaks more often involving chromosomes 7 and 11. Although karyotype instability may be a sign of cell transformation, the patient-derived eMSCs stopped cycling after about 26 passages and entered into replicative senescence. This shows that the karyotypic abnormalities that we observed in adenomyosis-derived eMSCs are not relevant to the cell transformation and immortalization in vitro. Similar content being viewed by others

References

Bouquet de Jolinière, J., Validire, P., Canis, M., Doussau, M., Levardon, M., and Gogusev, J., Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization, Hum. Reprod. Update, 1997, vol. 3, pp. 117–4. Brinton, L.A., Gridley, G., Persson, I., Baron, J., and Bergqvist, A., Cancer risk after a hospital discharge diagnosis of endometriosis, Am. J. Obstetrics Gynecol., 1997, vol. 176, pp. 572–4. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K.C., Keeney, G., Podratz, K.C., and Jenkins, R.B., Human epithelial ovarian cancer allelotype, Cancer Res., 1993, vol. 53, pp. 2393–4. De Hondt, A., Peeraer, K., Meuleman, C., Meeuwis, L., De Loecker, P., and D’Hooghe, T.M., Endometriosis and subfertility treatment: a review, Minerva Ginecol., 2005, vol. 57, pp. 257–4. Domnina, A.P., Fridlyanskaia, I.I., Zemelko, V.I., Pugovkina, N.A., Kovaleva, Z.V., Zenin, V.V., Grinchuk, T.M., and Nikolsky, N.N., Mesenchymal stem cells of human endometrium do not undergo spontaneous transformation during long-term cultivation, Cell Tissue Biol., 2013, vol. 55, pp. 69–4. Fukunaga, M., Nomura, K., Ishikawa, E., and Ushigome, S., Ovarian atypical endometriosis: its close association with malignant epithelial tumours, Histopathol., 1997, vol. 30, pp. 249–4. Gaetje, R., Kotzian, S., Herrmann, G., Baumann, R., and Starzinski-Powitz, A., Invasiveness of endometriotic cells in vitro, Lancet, 1995, vol. 346, pp. 1463–4. Gogusev, J., Bouquet de Jolinière, J., Telvi, L., Doussau, M., du Manoir, S., and Stojkoski, A., Detection of DNA copy number changes in human endometriosis by comparative genomic hybridization, Human Genet., 1999, vol. 105, pp. 444–4. Gogusev, J., Bouquet de Jolinière, J., Telvi, L., Doussau, M., du Manoir, S., Stojkoski, A., and Levardon, M., Genetic abnormalities detected by comparative genomic hybridization in a human endometriosisderived cell line, Mol. Hum. Reprod., 2000, vol. 6, pp. 821–4. Hompes, P.G. and Mijatovic, V., Endometriosis: the way forward, Gynecol. Endocrinol., 2007, vol. 23, pp. 5–4. Honchel, R., McDonnell, S., Schaid, D.J., and Thibodeau, S.N., Tumor necrosis factor-alpha allelic frequency and chromosome allelic imbalance in patients with colorectal cancer, Cancer Res., 1996, vol. 56, pp. 145–4. Jiang, W.P., Dewald, G., Brundage, E., Mucher, G., Schildhaus, H.U., Zerres, K., and Bond, J.S., Fine mapping of MEP1A, the gene encoding the a subunit of the metalloendopeptidase meprin, to human chromosome 6P21, Biochem. Biophys. Res. Commun., 1995, vol. 216, pp. 630–4. Jimbo, H., Yoshikawa, H., Onda, T., Yasugi, T., Sakamoto, A., and Taketani, Y., Prevalence of ovarian endometriosis in epithelial ovarian cancer, Int. J. Gynecol. Obstetrics., 1997, vol. 59, pp. 245–4. Kepkep, K., Tuncay, Y.A., Göynümer, G., and Tutal, E., Transvaginal sonography in the diagnosis of adenomyosis: which findings are most accurate?, Ultrasound Obstetrics Gynecol., 2007, vol. 30, pp. 341–4. Kihana, T., Hamada, K., Inoue, Y., Yano, N., Zketan, H., Murao, S., Ukita, M., and Matsuura, S., Mutation and allelic loss of the p53 gene in endometrial carcinoma incidence and outcome in 92 surgical patients, Cancer, 1995, vol. 76, pp. 72–4. Korner, M., Burckhardt, E., and Mazzucchelli, L., Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: a possible link to endometrioid adenocarcinoma, Modern Pathol., 2006, vol. 19, pp. 1615–4. Kosugi, Y., Elias, S., Malinak, L.R., Nagata, J., Isaka, K., Takayama, M., Simpson, J.L., and Bischoff, F.Z., Increased heterogeneity of chromosome 17 aneuploidy in endometriosis, Am. J. Obstetrics Gynecol., 1999, vol. 180, pp. 792–4. Lamb, K., Hoffmann, R.G., and Nichols, T.R., Family trait analysis: a case control study of 43 women with endometriosis and their best friends, Am. J. Obstet. Gynecol., 1986, vol. 154, pp. 596–4. Maheshwari, A., Gurunath, S., Fatima, F., and Bhattacharya, S., Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes, Human Reprod. Update, 2012, vol. 18, pp. 374–4. Malinak, L.R., Buttrum, V.C., Elias, S., and Simpson, J.L., Heritable aspects of endometriosis. II. Clinical characteristics of familial endometriosis, Am. J. Obstet. Gynecol., 1980, vol. 137, pp. 332–4. Matalliotakis, I.M., Kourtis, A.I., and Panidis, D.K., Adenomyosis, Obstetrics Gynecol. Clinics North Am., 2003, vol. 30, pp. 63–4. McManus, D.T., Yap, E.P.H., Maxwell, P., Russell, S.E.H., Toner, P.G., and McGee, J.D., p53 expression, mutation, and allelic deletion in ovarian cancer, J. Pathol., 1994, vol. 174, pp. 159–4. Meng, X., Ichim, T.E., Zchong, J., Rogers, A., Yin, Z., Jackson, J., Wang, H., Ge, W., Bogin, V., Chan, K.W., Thebaud, B., and Riordan, N.H., Endometrial regenerative cells: a novel stem cell population, J. Transl. Med., 2007, vol. 5, pp. 57–4. Missmer, S.A. and Cramer, D.W., The epidemiology of endometriosis, Obstetrics Gynecol. Clinics North Am., 2003, vol. 30, pp. 1–4. Moen, M.H. and Magnus, P., The familial risk of endometriosis, Acta Obstet. Gynecol. Scand., 1993, vol. 72, pp. 560–4. Moen, M.H., Endometriosis in monozygotic twins, Acta Obstet. Gynecol. Scand., 1994, vol. 73, pp. 59–4. Musina, R.A., Belyavsky, A.V., Tarusova, O.V., Solovieva, E.V., and Sukhikh, G.T., Endometrial mesenchymal stem cells derived from menstrual blood, Kl. Tehn. Biol. Med., 2008, vol. 2, pp. 110–4. Olive, D.L., and Schwartz, L.B., Endometriosis, N. Engl. J. Med., 1993, vol. 328, pp. 1759–4. Osborne, R.J. and Leech, V.L., PCR allelotyping of human ovarian cancer, Br. J. Cancer., 1994, vol. 69, pp. 429–4. Ozisik, Y.Y., Meloni, A.M., Surti, U., and Sandberg, A.A., Deletion 7q22 in uterine leiomyoma. A cytogenetic review, Cancer Genet. Cytogenet., 1993, vol. 71, pp. 1–4. Pandis, N., Karaiskos, C., Bardi, G., Sfikas, K., Tserkezoglou, A., Fotiou, S., and Heim, S., Chromosome analysis of uterine adenomyosis detection of the leiomyoma-associated del(7q) in three cases, Cancer Genet. Cytogenet., 1995, vol. 80, pp. 118–4. Ranney, B., Endometriosis. IV. Hereditary tendency, Obstet. Gynecol., 1971, vol. 37, pp. 734–4. Satoh, Y., Ishikawa, Y., Miyoshi, T., Mukai, H., Okumura, S., and Nakagawa, K., Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy, Virchows Arch., 2003, vol. 442, pp. 173–4. Sharpe-Timms, K.L., Basic research in endometriosis, Obstetrics Gynecol. Clinics North Am., 1997, vol. 24, pp. 269–4. Simpson, J.L., Elias, S., Malinak, L.R., and Buttram, V.C., Heritable aspects of endometriosis. I. Genetic studies, Am. J. Obstet. Gynecol., 1980, vol. 137, pp. 327–4. Tashiro, H., Isacson, C., Levine, R., Kurman, R.J., Cho, K.R., and Hedrick, L., p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis, Am. J. Pathol., 1997, vol. 150, pp. 177–4. Tibiletti, M.G., Bernasconi, B., Furlan, D., Riva, C., Trubia, M., Buraggi, G., Franchi, M., Bolis, P., Mariani, A., Frigerio, L., Capella, C., and Taramelli, R., Early involvement of 6q in surface epithelial ovarian tumors, Cancer Res., 1996, vol. 56, pp. 4493–4. Vincenti, V., Cassano, C., Rocchi, M., and Persico, M.G., Assignment of the vascular endothelial growth factor gene to human chromosome 6p21, Circulation, 1996, vol. 93, pp. 1493–4. Wang, P.H., Shyong, W.Y., Lin, C.H., Chen, Y.J., Li, Y.F., Chao, H.T., and Yuan, C.C., Analysis of genetic aberrations in uterine adenomyosis using comparative genomic hybridization, Anal. Quant. Cytol. Histol., 2002, vol. 24, pp. 1–4. Zemelko, V.I., Grinchuk, T.M., Domnina, A.P., Artzibasheva, I.V., Zenin, V.V., Kirsanov, A.A., Bichevaia, N.K., Korsak, V.S., and Nikolsky, N.N., Multipotent mesenchymal stem cells of desquamated endometrium: isolation, characterization and use as feeder layer for maintenance of human embryonic stem cell lines, Cell Tissue Biol., 2011, vol. 53, pp. 919–4. Ziegler, A., Field, L.L., and Sakagushi, A.Y., Report of the committee on the genetic constitution of chromosome 6, Cytogenet. Cell Genet., 1990, vol. 55, pp. 118–4. Author information Authors and Affiliations Corresponding author Additional information Original Russian Text © M.A. Shilina, A.P. Domnina, I.V. Kozhuharova, V.V. Zenin, S.V. Anisimov, N.N. Nikolsky, T.M. Grinchuk, 2015, published in Tsitologiya, 2015, Vol. 57, No. 11, pp. 771–779. Rights and permissions About this article Cite this article Shilina, M.A., Domnina, A.P., Kozhuharova, I.V. et al. Establishment and characterization of a novel human endometrial mesenchymal stem cell line from a patient with adenomyosis. Cell Tiss. Biol. 10, 10–17 (2016). https://doi.org/10.1134/S1990519X16010107 Received: Published: Issue date: DOI: https://doi.org/10.1134/S1990519X16010107

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (42)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK